Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting

• Published in: Medical oncology (Northwood, London, England) Vol. 35; no. 6; pp. 79 - 8
• Main Authors: Afram, Gabriel, Simón, Jose Antonio Pérez, Remberger, Mats, Caballero-Velázquez, Teresa, Martino, Rodrigo, Piñana, Jose Luis, Ringden, Olle, Esquirol, Albert, Lopez-Corral, Lucia, Garcia, Irene, López-Godino, Oriana, Sierra, Jordi, Caballero, Dolores, Ljungman, Per, Vazquez, Lourdes, Hägglund, Hans
• Format: Journal Article
• Language: English
• Published: New York Springer US 2018; Springer Nature B.V
• Subjects: ATG; Graft-versus-host disease (GVHD); Hematology; Internal Medicine; Medicin och hälsovetenskap; Medicine; Medicine & Public Health; Oncology; Original Paper; Pathology; Risk factor; Risk factors; ATG; Risk factor; Graft-versus-host disease (GVHD)
• ISSN: 1357-0560; 1559-131X; 1559-131X
• DOI: 10.1007/s12032-018-1127-2

Chronic graft-versus-host disease (cGVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Aim is to identify risk factors for the development of cGVHD in a multicenter setting. Patients transplanted between 2000 and 2006 were analyzed (
n
 = 820). Donors were HLA-identical siblings (57%), matched unrelated donors (30%), and HLA-A, B or DR antigen mismatched (13%). Reduced intensity conditioning (RIC) was given to 65% of patients. Overall incidence of cGVHD was 46% for patients surviving more than 100 days after HSCT (
n
 = 747). Older patient age [HR 1.15,
p
 < 0.001], prior acute GVHD [1.30,
p
 = 0.024], and RIC [1.36,
p
 = 0.028] increased overall cGVHD. In addition, RIC [4.85,
p
 < 0.001], prior aGVHD [2.14,
p
 = 0.001] and female donor to male recipient [1.80,
p
 = 0.008] increased the risk of severe cGVHD. ATG had a protective effect for both overall [0.41,
p
 < 0.001] and severe cGVHD [0.20,
p
 < 0.001]. Relapse-free survival (RFS) was impaired in patients with severe cGVHD. RIC, prior aGVHD, and female-to-male donation increase the risk of severe cGVHD. ATG reduces the risk of all grades of cGVHD without hampering RFS. GVHD prophylaxis may be tailored according to the risk profile of patients.